CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Biological sample and clinical data collectionWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.05

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales

The objectives of this study are to characterise immune responses in people with CoV-SARS-2 infection and use this knowledge to advance vaccine design, treatment options, and diagnostic reagents. Eligible participants will include people diagnosed with SARS-CoV-2 infection, and may include recently returned travellers and non-travellers in the community presenting to tertiary hospital healthcare facilities. Recruitment will be opportunistic, and sampling intensity may vary depending on the phase of the outbreak. Participants can be enrolled at any timepoint (up to 6 months) following diagnosis of SARS-CoV-2 infection (COVID-19). Blood samples and clinical data will be collected.

NCT04383652 COVID Other: Biological sample and clinical data collection
MeSH:Coronavirus Infections

Primary Outcomes

Description: The viruses will be sequenced to to help understand epitope specificity

Measure: Coronavirus sequencing

Time: 4 months post COVID-19 diagnosis.

Secondary Outcomes

Description: The viruses will then be either cultured to study the immune response against them in culture.

Measure: Coronavirus culturing

Time: 4 months post COVID-19 diagnosis.


No related HPO nodes (Using clinical trials)